<DOC>
	<DOCNO>NCT00723320</DOCNO>
	<brief_summary>The purpose study determine whether atorvastatin , aggressive lifestyle intervention , interaction effective delay progress pre-clinical atherosclerosis .</brief_summary>
	<brief_title>Effect Atorvastatin Lifestyle Intervention Progression Pre-Clinical Atherosclerosis</brief_title>
	<detailed_description>Primary prevention atherosclerotic disease remain big challenge . Currently , clear treat subject evidence pre-clinical atherosclerosis without obvious conventional risk factor . This randomized , placebo control , double blind study evaluate effect Atorvastatin 10 mg daily , therapeutic lifestyle change , combination , progression CIMT high baseline CIMT value belong 'high risk ' category , accord conventional risk factor .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>CIMT le 0.9 mm without Clinical diagnosis atherosclerotic disease without Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Therapeutic lifestyle change</keyword>
	<keyword>CIMT</keyword>
	<keyword>ABI</keyword>
	<keyword>PWV</keyword>
</DOC>